Viratech and Diabetes.net Sign Agreement

Published: Feb 21, 2013

STOCKTON, CA--(Marketwire - February 21, 2013) -

Highlighted Links

Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has entered into a letter of intent to provide a turn-key Social Network for Diabetes Network Charities at http//diabetes.net, for $250,000, plus 25% royalty from all revenue derived from the operation of the site.

"Viratech's method of broadcasting and building content through user generated content is innovative and clever, and I am extremely excited that Diabetes.net will be a part of it," said Diabetes.net founder G. Ford Gilbert.

"We are excited Diabetes.net, being the original diabetes network for researchers, physicians and healthcare professionals, further validates our innovative patient centric social platform," said Viratech CEO, Dr. Kevin Buckman.

Viratech will provide a turnkey social network, leveraging its intellectual property and patient interactive platform that will help spread the word of new solutions with the goal of becoming the one-stop site for diabetes.

About Diabetes.net

Diabetes.net is the original diabetes network for researchers, physicians and healthcare professionals. Diabetes mellitus is a group of metabolic diseases characterized by improper metabolism due to the inability of the pancreas to produce enough insulin, or the lack of response of cells to the insulin that is produced. As of 2010, an estimated 285 million people worldwide were afflicted with diabetes, and the number is expected to almost double by 2030. In the United States the CDC has classified the disease as epidemic. Diabetes.net is the original diabetes network of researchers, physicians, and health care professionals, promoting research on diabetes treatments and cures for over 25 years.

About Viratech Corp.

Based in Stockton, California, Viratech Corp., which just launched Cancer.im, http://www.youtube.com/watch?v=dz1tHRb3wvU, has created an open source biotech research and development platform, leveraging the utility of social collaboration, which will allow biotech research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Using this platform, Viratech members can protect their intellectual property, then use Viratech's micro social network as a utility to promote and crowdfund the research and development to produce the new technology.